J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
1,678.30
-28.10 (-1.65%)
Oct 31, 2025, 3:29 PM IST
NSE:JBCHEPHARM Market Cap
NSE:JBCHEPHARM has a market cap or net worth of 263.11 billion as of October 31, 2025. Its market cap has decreased by -7.52% in one year.
Market Cap
263.11B
Enterprise Value
258.88B
Revenue
40.08B
Ranking
n/a
PE Ratio
38.40
Stock Price
1,678.30
Market Cap Chart
Since December 11, 2001, NSE:JBCHEPHARM's market cap has increased from 408.70M to 263.11B, an increase of 64,275.89%. That is a compound annual growth rate of 31.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 263.11B | -8.31% |
| Dec 31, 2024 | 286.94B | 13.93% |
| Dec 29, 2023 | 251.85B | 67.53% |
| Dec 30, 2022 | 150.33B | 9.43% |
| Dec 31, 2021 | 137.38B | 74.76% |
| Dec 31, 2020 | 78.61B | 130.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.79T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.10T |
| Mankind Pharma | 984.02B |
| Zydus Lifesciences | 980.52B |
| Fortis Healthcare | 772.36B |
| Aurobindo Pharma | 661.47B |